International audiencePurpose. A randomized cross-over, double blind placebo controlled study of smoked cannabis was carried out on occasional cannabis smokers. The objective of this research was to describe the pharmacokinetic parameters of THC and its metabolites in plasma, oral fluid and urine, from samples obtained simultaneously to provide estimations of THC and metabolites concentrations after smoking a cannabis cigarette. Methods. Blood, oral fluid and urine samples were collected until up to 72 h after smoking the cannabis cigarette (4% of delta-9-tetrathydrocannabinol (THC)). THC, 11-OH-THC and THC-COOH were analyzed by gas-chromatography-mass spectrometry. Pharmacokinetic parameters were estimated from these data. Results. Eightee...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
International audiencePurpose. A randomized cross-over, double blind placebo controlled study of smo...
"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...
"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...
"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...
"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...
A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...
A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...
Cannabinoid pharmacokinetics in occasional users is well studied, but the interpretation of data fro...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
Cannabinoid pharmacokinetics in occasional users is well studied, but the interpretation of data fro...
Cannabinoid pharmacokinetics in occasional users is well studied, but the interpretation of data fro...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
International audiencePurpose. A randomized cross-over, double blind placebo controlled study of smo...
"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...
"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...
"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...
"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...
A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...
A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...
Cannabinoid pharmacokinetics in occasional users is well studied, but the interpretation of data fro...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
Cannabinoid pharmacokinetics in occasional users is well studied, but the interpretation of data fro...
Cannabinoid pharmacokinetics in occasional users is well studied, but the interpretation of data fro...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...
International audienceTo develop a population pharmacokinetic (PP) model of delta-9-tetrahydrocannab...